GABA is synthesized by two isoforms of glutamate decarboxylase (GAD), GAD65, and GAD67. However, the relative contributions of GAD65-mediated GABA synthesis to the in vivo actions of anesthetics remain unknown. To address this issue, we used mice deficient in the 65-kDa isoform of GAD and tested the hypothesis that partial reduction of GABA content in GAD65-deficient mice [GAD65(Ϫ/Ϫ)] would contribute to hypnotic and immobilizing actions of the anesthetics. The open field test, loss of righting reflex (LORR), loss of tail-pinch withdrawal response (LTWR), and locomotor activity were compared between wild-type (WT) mice and GAD65(Ϫ/Ϫ) mice. Effects of general anesthetics on both phasic and tonic GABAergic currents were examined using the patch-clamp method in frontal cortex pyramidal neurons in brain slices. The duration of propofol (100 mg/kg i.p.)-induced LORR and the duration of propofol (150 mg/kg i.p.)-induced LTWR in GAD65(Ϫ/Ϫ) mice were significantly reduced compared with WT mice. In contrast, no difference was seen for ketamine. Preinjection of the GABA transporter 1 inhibitor, NO-711 (C 21 H 22 N 2 O 3 ⅐ HCl) (0.75 mg/kg i.p.), reinstated diminished actions of propofol in GAD65(Ϫ/Ϫ) mice. Cortical pyramidal neurons in GAD65(Ϫ/Ϫ) mice had smaller tonic conductances, and propofol-induced enhancement of tonic inhibition was smaller than in WT mice, suggesting that genotype differences in GAD65-mediated GABAergic inhibitory tone may be, at least in part, a cellular basis underlying behavioral differences. In conclusion, GAD65(Ϫ/Ϫ) mice show a diminished response to propofol, but not ketamine, indicating that GAD65-mediated GABA synthesis plays an important role in hypnotic and immobilizing actions of propofol.
in the control of the synaptic release of GABA in times of high GABA demand. Although levels of GAD67 mRNA and protein are largely unchanged by the GAD65 mutation (Asada et al., 1996) , GABA content in the amygdala, hypothalamus, and parietal cortex in GAD65(Ϫ/Ϫ) mice is approximately half of wild-type (WT) mice (Stork et al., 2000) . However, the relative contributions of GAD65-mediated GABA to the in vivo actions of general anesthetics remain to be established.
To address this issue, the present study used mice lacking the GAD65 gene. In sharp contrast to GAD67(Ϫ/Ϫ) mice, which exhibit a perinatal lethal phenotype (Asada et al., 1997) , GAD65(Ϫ/Ϫ) mice are viable and fertile, and gross behaviors appeared to be normal without apparent anatomical deficits. The smaller isoform GAD65 has been suggested to be involved in generating GABA for rapid release and implicated in the fine-tuning of inhibitory neurotransmission. Thus, GAD65-mediated GABA may play an important role for general anesthetic-induced neural inhibition. However, our understanding of the role of GAD65 in anestheticinduced modulation is quite limited. To clarify the influence of the GAD65 gene knockout in anesthetic-induced neural inhibition, the present study investigated behavioral responses to propofol, an anesthetic thought to act via enhanced GABA inhibition, and ketamine, which appears to target N-methyl-D-aspartate receptors and other non-GABA sites, in mice lacking the GAD65 gene in vivo, and synaptic responses in vitro using brain slice preparations. This study tested the hypothesis that GAD65(Ϫ/Ϫ) mice would demonstrate altered sensitivity to general anesthetics in vivo and whether spontaneous GABA release and tonic inhibition would play a significant role in anesthetic-induced hypnotic and immobilizing actions.
Materials and Methods
Mice. All animal procedures and protocols used in this study were approved by the Animal Care Committee of the Gunma University Graduate School of Medicine (protocol no. 05-71) and were performed according to the Guide for Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) . The generation of GAD65(Ϫ/Ϫ) mice has been described previously (Yanagawa et al., 1999; Yamamoto et al., 2004) . These GAD65(Ϫ/Ϫ) mice were backcrossed to C57BL/6 mice more than 10 times, and then they were used for our experiments. Adult male WT mice and GAD65(Ϫ/Ϫ) mice from 12 to 16 weeks old weighing 23 to 28 g were used for experiments. Mice were group-housed in a pathogen-free transgenic facility, and water and food were available ad libitum. None of the animals was used for more than two experiments, and at least 1 week was allowed for the mice to recover.
Behavioral Assays. Loss of righting reflex (LORR) was used as a surrogate measure for hypnosis. Each animal received an intraperitoneal injection of propofol or ketamine and were then placed on their backs in a chamber (20 ϫ 28 ϫ 15 cm), and the ability to right themselves was observed. Mice were judged to have lost this reflex when unable to right themselves within 10 s. The time from intraperitoneal injection of the drug to LORR was considered as the latency, and the time between the LORR and the time mice regained the ability to right themselves within 2 s was considered the duration of LORR. Two behavioral assays were used as a surrogate measure for immobilization: loss of tail-pinch withdrawal response (LTWR) and loss of hind-limb withdrawal reflex (LHWR) (Quasha et al., 1980; Arras et al., 2001) . The tail-pinch assay is known to reflect the supraspinal nociceptive response, whereas LHWR is thought to be largely mediated by spinal cord circuitry. The LHWR, which occurs at higher concentrations, serves as a surrogate measure for surgical tolerance (Arras et al., 2001) . The duration of anesthetic-induced loss of these reflexes was measured. A surgical spring clip (6 mm in size; Applied Medical, Rancho Santa Margarita, CA) was placed at the base of an animal's tail or hind-limb for 5 s at 1-min intervals.
Spontaneous activity was measured in the Plexiglas transparent open field. Their movements were tracked for 20 min by using an infrared photo-beam detection system for locomotor activity (LSI LETICA, LE 8811; Panlab, S.L., Barcelona, Spain). This system allowed us to analyze animal trajectories with 16 ϫ 16 infrared beams for optimal subject detection. Behavioral data were stored for a computer for later analysis. To test motor coordination and equilibrium, animals were placed on the rotating Rotorod apparatus (LETICA), where the rotational speed of the rod was kept constant at 10 rpm. Mice were trained to remain on a Rotorod until they could perform three consecutive 180-s trials. Mice were then dosed with NO-711 (3 mg/kg i.p.) and, 20 min later, were given a single Rotorod trial. The latency to fall from the rod was recorded and compared between genotypes.
Electrophysiological Recordings. The methods used have been described previously (Nishikawa and MacIver, 2000; Nishikawa et al., 2005) . In brief, mice were decapitated under anesthesia, and the brain was immediately immersed in a cold (1-4°C) modified Ringer solution, comprised 234 mM sucrose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 10 mM MgSO 4 , 0.5 mM CaCl 2 , 26 mM NaHCO 3 , and 11 mM glucose, saturated with 95% O 2 and 5% CO 2 . Slices (500 m) were cut from the brain, then kept in the prechamber filled with artificial cerebrospinal fluid (ACSF) consisting of 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , and 11 mM glucose, and bubbled with 95% O 2 and 5% CO 2 for at least 1 h for recovery. Slices were transferred to a recording chamber (1.0 ml in volume), mounted on the stage of an upright Axioskop2 FS plus microscope (Carl Zeiss GmbH, Jena, Germany), and perfused at a rate of approximately 3 ml/min, with an oxygenated ACSF. Patch electrodes were made from borosilicate thinwalled capillaries (GDC-1.5; Narishige, Tokyo, Japan). The pipette resistance was 5-7 M⍀ when filled with a potassium chloride (KCl)-based internal solution adjusted to pH 7.3, 295 Ϯ 5 mOsm containing 140 mM KCl, 10 mM EGTA, 10 mM HEPES, 2 mM MgCl 2 , 1 mM CaCl 2 , 2 mM Mg-ATP, and 0.1 mM spermine. An Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) was used for wholecell recordings. Whole-cell currents were filtered at 2 to 5 kHz and digitized at 10 kHz and stored for later analysis. GABA A receptormediated IPSCs were pharmacologically isolated by bath application of (Ϯ)-2-amino-5-phosphonopentanoic acid (100 M) and 6-cyano-7-nitro-quinoxaline-2, 3-dione (20.0 M) to block N-methyl-D-aspartate and ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptormediated synaptic currents. Series resistances were generally between 10 and 25 M⍀ and were then compensated approximately 80%. Field excitatory postsynaptic potentials (fEPSPs) and population spikes (PSs) in the CA region of the hippocampus were also recorded as described previously (Ishizeki et al., 2008) . All recordings were performed at room temperature (22-24°C).
Data Analysis. Data acquisition and analysis were performed with pCLAMP software version 8.1 (Molecular Devices). The amplitude of synaptic current was measured from the initial inflection point (not from the baseline) to the peak to avoid the effects of summation on amplitude distribution. Threshold-level crossing was set at approximately 3-fold of baseline noise; as a result, synaptic currents larger than 6 pA in the amplitude were counted for analysis. The decay phase was fitted with a single exponential curve, and a time from peak to 1/e was defined as the decay time constant. Statistical analysis was performed using StatMate III (ATMS, Tokyo, Japan). Statistical significance was determined at the P Ͻ 0.05 level using the Student's t test or ANOVA with a post hoc Tukey test. Data were expressed as mean Ϯ S.D.
Chemicals. In electrophysiological experiments, propofol (Wako Pure Chemicals, Osaka, Japan) was dissolved in dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO), such that the maximal final jpet.aspetjournals.org concentration of the DMSO was less than 0.5%, to produce a 10 mM stock solution. In control experiments, this DMSO concentration had no effect on IPSCs. Ketamine hydrochloride (Sankyo Co., Ltd., Tokyo, Japan) was dissolved in distilled water to produce a 10 mM stock solution. These stock solutions were diluted in ACSF solution to achieve the appropriate concentrations for applying to slice preparations. For behavioral studies, mice were treated with propofol (Maruishi Pharmaceuticals Co., Ltd., Osaka, Japan) or ketamine (Sankyo Co., Ltd.) administered intraperitoneally with a volume of 10 l/g body weight. Vehicle solutions for behavioral studies were as follows: propofol, 10% lipofundin MCT/LCT (B. Braun Melsungen AG, Mulsungen, Germany), ketamine, and 0.9% saline. An intraperitoneal injection of 10% lipofundin MCT/LCT (10 l/g) alone had no hypnotic/analgesic effect on mice behavior (n ϭ 5, data not shown). Other drugs were purchased from Sigma-Aldrich.
Results
Behavioral Responses to Propofol, But Not Ketamine, Are Diminished in GAD65(؊/؊) Mice. To evaluate behaviorally the effects of propofol and ketamine in WT and GAD65(Ϫ/Ϫ) mice, different endpoints of anesthetic state were measured. The duration of LORR was used as a measure for hypnosis. Propofol produced LORR in both genotypes (Fig. 1A , left); however, GAD65(Ϫ/Ϫ) mice (n ϭ 12) showed reduced sensitivity to propofol (ED 50 , 55.9 mg/kg) compared with WT mice (ED 50 , 46.2 mg/kg). In contrast, no genotype difference was found for ketamine-induced LORR (ED 50 , 34.6 mg/kg for WT mice; 29.9 mg/kg for GAD65(Ϫ/Ϫ) mice, Fig. 1A , right). As shown in Fig. 1B , the latency to LORR produced by propofol (100 mg/kg i.p.) was significantly prolonged in GAD65(Ϫ/Ϫ) mice (176.2 Ϯ 31.2 s) than that of WT mice (147.6 Ϯ 27.5 s, P Ͻ 0.01; Fig. 1B, left) .
Inhibition of GABA uptake or metabolism is a strategy for enhancing GABAergic inhibitory tone. GABA is cleared from the synaptic cleft by specific, high-affinity, sodium-and chloride-dependent transporters, which are thought to be located on presynaptic terminals and surrounding glial cells. Molecular cloning has revealed the existence of genes for four distinct GABA transporters (GAT-1, GAT-2, GAT-3, and betaine transporter type 1) (Borden, 1996) . GAT-1 is responsible for a majority of neuronal GABA transport. We then tested whether the selective GAT-1 inhibitor, NO-711, would affect LORR in GAD65(Ϫ/Ϫ) mice. Preinjection of the GABA transporter 1 inhibitor, NO-711 (0.75 mg/kg i.p.), reinstated the latency in GAD65(Ϫ/Ϫ) mice, suggesting that GABA content plays an important role for anesthetic induction of propofol. In contrast, the latency to LORR by ketamine (100 mg/kg i.p.) was similar between genotypes (P ϭ 0.56, Fig. 1B , right). GAD65(Ϫ/Ϫ) mice also showed a significant reduction in the duration of LORR (915.1 Ϯ 444.5 s, n ϭ 16) produced by propofol (100 mg/kg i.p.) compared with WT mice (1486. 2 Ϯ 653.3, n ϭ 18, P Ͻ 0.01, Fig. 1C , left). Preinjection of NO-711 (0.75 mg/kg i.p.) reinstated the duration of LORR by propofol (100 mg/kg i.p.). In contrast, the duration of LORR was similar for ketamine (100 mg/kg i.p., P ϭ 0.26, Fig. 1C , right). In the Rotorod assay, both WT mice (n ϭ 6) and GAD65(Ϫ/Ϫ) mice (n ϭ 5 each) could stay on rotating bar over 180 s in three consecutive trials. In addition, NO-711 injection (up to 3.0 mg/kg) did not affect the latency to fall from the rod, and both genotypes could stay on the bar over 180 s. These data suggest that reduction or enhancement in GABAergic tone at the tested range has little effect on motor coordination.
The LTWR was used as a surrogate measure for immobilization (Quasha et al., 1980) . Propofol (150 mg/kg i.p.) induced a loss of this reflex in all mice, but the duration was significantly diminished in GAD65(Ϫ/Ϫ) mice compared with WT mice; a 31% reduction in the duration was observed in GAD65(Ϫ/Ϫ) mice (P Ͻ 0.05, n ϭ 8, Fig. 1D, left) . In contrast, the duration of LTWR was statistically similar for ketamine (250 mg/kg i.p., P ϭ 0.67, Fig. 1D, right) . With regard to immobilizing response, significant differences between genotypes were apparent in response to propofol injection. We then measured the duration of LHWR as a measure of the Fig. 1 . Altered anesthetic responses to propofol, but not ketamine, in GAD65(Ϫ/Ϫ) mice. A, dose-response analysis for propofol or ketamine causing the LORR is shown. Propofol or ketamine was administered intraperitoneally. The fitted curves were generated using a weighted sum of the least-squares method (KaleidaGraph version 3.5; Synergy Software, Reading, PA) to a Hill equation:
, where LORR is a percentage of LORR, [drug] is the anesthetic concentration, and n H is the Hill coefficient. ED 50 values for propofol are 46.2 mg/kg in WT mice and 55.9 mg/kg in GAD65(Ϫ/Ϫ) mice. ED 50 values for ketamine are 34.6 mg/kg in WT mice and 29.9 mg/kg for GAD65(Ϫ/Ϫ) mice. B, latency to LORR recorded from the time of propofol or ketamine injection. A significant prolongation of the latency by propofol (100 mg/kg) was observed in GAD65(Ϫ/Ϫ) mice (ANOVA with a post hoc Tukey test; ‫,ءء‬ P Ͻ 0.01 between genotypes). GAT1 inhibitor NO-711 was administered intraperitoneally 20 min before propofol injection. C, duration of LORR produced by propofol (100 mg/kg) was significantly reduced in GAD65(Ϫ/Ϫ) mice (ANOVA with a post hoc Tukey test; ‫,ءء‬ P Ͻ 0.01). Data bars represent mean Ϯ S.D. D, duration of LTWR produced by propofol (150 mg/kg i.p.) was significantly reduced in GAD65(Ϫ/Ϫ) mice (Student's t test, n ϭ 8; ‫,ء‬ P Ͻ 0.05). However, no differences were detected for ketamine (250 mg/kg i.p., Student's t test, n ϭ 8 for WT, n ϭ 9 for GAD65(Ϫ/Ϫ) mice, P ϭ 0.67). Data bars show mean Ϯ S.D. immobilizing response to a noxious stimulus, which occurs at higher concentrations and is a sensitive indicator of surgical tolerance in mice (Arras et al., 2001) . Propofol (150 mg/kg i.p.) or ketamine (250 mg/kg i.p.) failed to induce LHWR in both genotypes (n ϭ 10 each), although both anesthetics produced respiratory depression in some mice and were associated with approximately 10 -15% mortality rates. These results suggest that much higher concentrations of propofol, which are close to lethal doses, are needed to observe complete loss of this reflex.
Spontaneous locomotor activity in the open field was compared between WT and GAD65(Ϫ/Ϫ) mice. Total distance traveled was measured for 20 min from the time of anesthetic injection. No genotype difference in locomotor activity was observed in the absence of the anesthetic and after anesthetic injection ( Fig. 2A) , although propofol (100 mg/kg i.p.) or ketamine (100 mg/kg i.p.) produced a profound depression in total distance (P Ͻ 0.001 versus control). Because we found that propofol or ketamine at a subanesthetic dose produced variable locomotor activity during the latency to LORR, we then measured active time and resting time during the 20-min observation period. Active time was defined as observation period Ϫ resting time (seconds), and resting time was the time period during which the speed of the subjects was below the resting threshold (LSI LETICA, LE 8811; Panlab, S.L.). WT mice were active for 1019 Ϯ 65 s (n ϭ 10) in the absence of anesthetic and GAD65(Ϫ/Ϫ) mice for 1011 Ϯ 74 s. As expected, propofol (100 mg/kg i.p.) decreased active time to 231 Ϯ 131 s in WT and to 261 Ϯ 69 s in GAD5(Ϫ/Ϫ) mice. Ketamine (100 mg/kg i.p.) decreased to 486 Ϯ 201 s in WT and to 517 Ϯ 211 s in GAD65(Ϫ/Ϫ) mice. We then calculated the total distance traveled per active time (Fig. 2B) . Propofol (20 mg/kg i.p.) significantly increased distance traveled per active time in WT mice compared with control (n ϭ 15, P Ͻ 0.01) and compared with GAD65(Ϫ/Ϫ) mice (n ϭ 10, P Ͻ 0.05). In contrast, no genotype difference was found for ketamine (Fig. 2B) .
The percentage of distance traveled in the inner versus outer region of the open field differed significantly between genotypes (Fig. 2C) . GAD65(Ϫ/Ϫ) mice traveled significantly more in the periphery of the open field (76.1 Ϯ 9.3%, n ϭ 15) compared with WT mice (66.4 Ϯ 8.9%, P Ͻ 0.01). GAD65(Ϫ/Ϫ) mice also spent significantly more time in the outer region of the open field (WT, 58.9 Ϯ 9.6% versus GAD65(Ϫ/Ϫ), 70.0 Ϯ 10.8%; n ϭ 15, P Ͻ 0.05, Fig. 2D ). These observations are consistent with previous findings that GAD65(Ϫ/Ϫ) mice showed increased anxiety-like responses in the behavioral assay .
Basal Excitatory Synaptic Transmission Is Normal in the CA1 Region of Hippocampus in GAD65(؊/؊) Mice. Given these effects of the loss of GAD65 on hypnotic and immobilizing actions of the anesthetic in vivo, we next tried to provide physiological evidence for the role of GAD65 in central synaptic transmission. We first compared properties of Schaffer-collateral-commissural fiber-evoked fEPSPs and anesthetic sensitivity. The responses to individual stimuli (Fig. 3A) and the dependence of the initial slope of fEPSPs on the stimulating current (Fig. 3B) were essentially normal in GAD65(Ϫ/Ϫ) mice. Paired-pulse ratios of fEPSP amplitudes at interstimulus intervals ranging from 20 to 180 ms were also normal in the GAD65(Ϫ/Ϫ) mice (Fig. 3C) . Although propofol (30 M, 20 min) significantly depressed the amplitude of fEPSP to a similar degree, ketamine (10 M) had no effect on these predominantly AMPA receptor-mediated fEPSP responses (Fig. 3D) .
Propofol-Induced Depression of Neural Excitability of CA1 Neurons Is Similar in GAD65(؊/؊) Mice. PS responses from CA1 neurons were used to monitor neural excitability. A specific GABA A receptor antagonist, SR95531 (1 M), selectively blocks only synaptic GABA A receptors that generate IPSCs in CA1 neurons, whereas bicuculline (BIC) blocks both synaptic and extrasynaptic tonic conductances (Yamada et al., 2007) . SR95531 does not affect GABAtransaminase or glutamate-decarboxylase activities. Propofol (30 M) significantly depressed PS amplitude in WT mice (33.1 Ϯ 9.6% of control, n ϭ 5, P Ͻ 0.001, Fig. 3E ). Although SR95531 (1 M) had no effect on the amplitude, additional application of BIC (10 M) significantly reversed the amplitude (70.7 Ϯ 11.7% of WT control, P Ͻ 0.01). Propofol had similar actions on PS amplitude in GAD65(Ϫ/Ϫ) mice; BIC significantly reversed PS amplitude in the continued presence of SR95531 (1 M) (P Ͻ 0.01, Fig. 3F ). These data suggest that tonic inhibition, which is reversed by BIC (10 A, propofol (100 mg/kg i.p.) or ketamine (100 mg/kg i.p.) significantly decreased total distance traveled for 20 min after anesthetic injection (ANOVA with a post hoc Tukey test, P Ͻ 0.001 versus baseline). There were no differences in total distance traveled between genotypes (Student's t test, n ϭ 15 each). B, total distance traveled divided by active time was calculated. Propofol (20 mg/kg i.p.) produced an increase in distance/active time in WT mice (ANOVA with a post hoc Tukey test; ‫,ءء‬ P Ͻ 0.01 versus baseline). Significant difference between genotypes was also found after propofol (20 mg/kg i.p.) administration (Student's t test; #, P Ͻ 0.05). C, regional distance traveled was compared between genotypes (Student's t test; ‫,ءء‬ P Ͻ 0.01, n ϭ 15). D, regional dwell time was compared between genotypes. Data bars, mean Ϯ S.D. (Student's t test; ‫,ء‬ P Ͻ 0.05, n ϭ 15). The Effects of Propofol and Ketamine on Miniature Inhibitory Postsynaptic Currents in the Frontal Cortex. We then looked at the influence of deleting GAD65 gene on spontaneous GABAergic synaptic currents in frontal cortical neurons (layer V). GABA A receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) were recorded from the frontal cortex layer V pyramidal neurons at Ϫ60 mV using KCl-based internal solutions in the presence of 1 M tetrodotoxin (Fig. 4A) . The amplitude of mIPSCs either displayed as the mean amplitude (12.9 Ϯ 3.5 pA in WT mice and 11.9 Ϯ 4.7 pA in GAD65(Ϫ/Ϫ) mice, n ϭ 8 each, Fig. 4B, top) or as a cumulative probability distribution (Fig. 4B, bottom) was unchanged in GAD65(Ϫ/Ϫ) mice. Propofol up to 30 M had no effect on mean amplitude of mIPSCs (15.1 Ϯ 5.1 pA in WT mice and 11.0 Ϯ 4.9 pA in GAD65(Ϫ/Ϫ) mice, n ϭ 8 each, Fig. 4B ). The rise time and the decay time of mIPSCs were also similar between genotypes (WT mice, 0.8 Ϯ 0.2 ms in the rise time, 19.0 Ϯ 5.5 ms in the decay, n ϭ 10; GAD65(Ϫ/Ϫ) mice, 0.9 Ϯ 0.3 ms in the rise time, 19.8 Ϯ 4.9 ms in the decay, n ϭ 10).
Reduced Sensitivity to Propofol in GAD65 Knockout
Although propofol (1 M, 20 min) had no effect on the frequency of mIPSCs, propofol (30 M, 20 min) significantly increased the frequency of mIPSCs in WT mice (n ϭ 8, P Ͻ 0.05 versus WT control, P Ͻ 0.01 versus GAD65(Ϫ/Ϫ)). However, propofol up to 30 M failed to increase the frequency in GAD65(Ϫ/Ϫ) mice (Fig. 4C) . Propofol (30 M, 20 min) prolonged the decay of mIPSCs [176 Ϯ 23% of control in WT mice (n ϭ 8, P Ͻ 0.001), 168 Ϯ 29% of control in GAD65(Ϫ/Ϫ) mice (n ϭ 8, P Ͻ 0.001, Fig. 4D) ]. In contrast, ketamine up to 10 M was found to have no significant effect on mIPSCs in both genotypes (data not shown). These data are consistent with previous findings that ketamine has no effect on GABA receptors at concentrations as high as 100 M (Yamakura et al., 2000) .
The effects of picrotoxin (PIC) on the holding current were examined in the absence of the anesthetic. Although PIC (50 M) produced an outward shift in both genotypes, the amplitude of tonic current was slightly but significantly smaller in GAD65(Ϫ/Ϫ) mice (Fig. 4E) . Propofol (30 M, 20 min) produced an inward shift in I hold of GAD65(Ϫ/Ϫ) mice (Fig.  4A ). Bath application of SR95531 (1 M) completely blocked mIPSCs but had little effect on tonic current, whereas additive application of PIC (10 M) fully blocked the tonic current. Figure 4F summarizes the effects of propofol, SR95531 (1 M), and PIC (50 M) on the tonic current. Propofol (30 M) produced an inward shift in I hold in GAD65(Ϫ/Ϫ) mice (Ϫ22.0 Ϯ 3.1 pA, n ϭ 8, P Ͻ 0.001 versus control), which was significantly smaller than that observed in WT mice (Ϫ29.9 Ϯ 4.5 pA, n ϭ 8, P Ͻ 0.01). The tonic current was only partially but not significantly reversed by 1 M SR95531 (Ϫ28.2 Ϯ 4.1 pA in WT mice; Ϫ20.5 Ϯ 3.5 pA in GAD65(Ϫ/Ϫ) mice, n ϭ 8), whereas the phasic current was completely blocked in both genotypes. Additive application of PIC (50 M) blocked the tonic current and produced an outward shift in I hold in GAD65(Ϫ/Ϫ) mice (15.2 Ϯ 3.3 pA, n ϭ 8); however, the degree of the shift was significantly smaller than that in WT mice (20.3 Ϯ 2.0 pA, n ϭ 8, P Ͻ 0.01).
Discussion
Using mice with a targeted disruption of the GAD65 gene, we investigated the functional contribution of GAD65 to an- Fig. 3 . A, representative fEPSPs recorded in the CA1 region in response to different stimulation intensities (3.0 -6.0 mV). B, averaged dependence of the amplitude of fEPSPs on stimulating current (n ϭ 5 each). C, paired-pulse facilitation was similar between genotypes at each stimulus interval (ANOVA, n ϭ 5 each). The stimulus interval was changed from 20 to 180 ms without changing the stimulus intensity. D, propofol (30 M) depressed the amplitude of fEPSP (Student's t test, P Ͻ 0.001 versus control, n ϭ 5), whereas ketamine (10 M) had no effect on the amplitude. E, PS responses were recorded from CA1 neurons in response to electrical stimulation of SCC fibers. F, bar graph summarizes the effects of propofol (30 M), SR95531 (1 M), and BIC (10 M) on PS amplitude (ANOVA for multiple groups, statistical analysis between genotypes was made by the Student's t test). Data are presented as mean Ϯ S.D. jpet.aspetjournals.org esthetic-induced neural inhibition. GAD65(Ϫ/Ϫ) mice appeared to display reduced sensitivity to propofol, but not ketamine, in the LORR and LTWR assay and increased anxiety-like responses in the behavioral assay. Propofol increased the frequency of mIPSCs in WT mice, but not GAD65(Ϫ/Ϫ) mice. As a result, propofol-induced enhancement of GABAergic tonic inhibition was significantly smaller in GAD65(Ϫ/Ϫ) mice. Taking this evidence together, GAD65-mediated GABA synthesis plays an important role in hypnotic and immobilizing actions of propofol in vivo. Tonic inhibition seems to be enhanced by GAD65-mediated synthesis of GABA, and a decrease in GABA synthesis seems to contribute, at least in part, to diminished actions of propofol in the knockout mice.
Behavioral Assays. At the behavioral level, GAD65(Ϫ/Ϫ) mice showed significantly reduced sensitivity to propofol in the LORR assay, confirming the hypothesis that partial loss of endogenous GABA tone contributes to the reduced hypnotic actions of propofol in vivo. GABA is taken up by four distinct GATs, and the major subtype, GAT1, is particularly abundant in areas rich in GABAergic neurons, such as the hippocampus, neocortex, and cerebellum (Borden, 1996) . The GAT1 inhibitor, NO-711, reinstated diminished propofol actions in GAD65(Ϫ/Ϫ) mice, indicating that enhanced GABA content compensates loss of inhibition by GAD65 gene knockout in terms of propofol sensitivity. These results support the idea that GAD65-mediated inhibitory tone plays a significant role in propofol-induced hypnotic action.
GAD65(Ϫ/Ϫ) mice showed significantly reduced sensitivity to propofol in the tail-pinch assay, suggesting that GAD65-mediated GABA contributes to immobilizing responses to propofol via supraspinal mechanisms. However, propofol (150 mg/kg i.p.) failed to induce LHWR, a surrogate measure for surgical tolerance, in both genotypes. The suppression of noxious-evoked withdrawal reflexes is thought to be largely mediated by spinal cord circuitry (Ma and Woolf, 1996) . Thus, it is likely that propofol (150 mg/kg i.p.), which produces LORR and LTWR, is insufficient to depress nociceptive responses at the spinal cord level. In this context, the effects of propofol on the superficial dorsal horn, including substantia gelatinosa neurons, are of interest because this area is the first region to receive mechanical nociceptive input from the periphery, GABAergic inputs from nearby interneurons (Chéry and de Koninck, 1999) , and descending fibers (Kato et al., 2006) . GABAergic tonic current has been identified in subpopulations of substantia gelatinosa neurons in mouse spinal cord slice preparations (Takahashi et al., 2006) , suggesting that propofol at higher concentrations suppresses nociceptive responses by enhancing tonic inhibition and phasic inhibition. Note that propofol (30 M) produced inward shift and prolonged the decay of mIPSCs in GAD65(Ϫ/Ϫ) mice (bottom). B, deleting GAD65 had no effect on the amplitude of mIPSCs (top) and on the cumulative probability of mIPSCs (bottom) in the absence of propofol. Propofol up to 30 M (20 min) had no effect on the amplitude of mIPSCs (ANOVA). C, propofol (30 M, 20 min) increased the frequency (2.6 Ϯ 0.8 Hz in control to 4.8 Ϯ 1.9 Hz in the presence of propofol) but not in GAD65(Ϫ/Ϫ) mice ‫,ء(‬ P Ͻ 0.05 versus WT control; ##, P Ͻ 0.01 versus GAD65(Ϫ/Ϫ), ANOVA). D, propofol prolonged the decay of mIPSCs to a similar degree in both genotypes. E, effects of PIC on holing current in the absence of the anesthetic. PIC-induced outward current from pyramidal neurons in the frontal cortex was shown (WT, 24.1 Ϯ 2.9 pA; GAD65(Ϫ/Ϫ), 16.2 Ϯ 5.1 pA; Student's t test; n ϭ 6; ‫,ءء‬ P Ͻ 0.01). PIC (50 M, 20 min) was added to ACSF solution. F, effects of propofol, SR95531, and PIC on holding current were summarized. Propofol (30 M, 20 min), SR95531 (1 M, 20 min), and picrotoxin (10 M, 20 min) were added to the recording chamber (ANOVA for multiple groups, statistical analysis between genotypes was made by the Student's t test; ‫,ءءء‬ P Ͻ 0.001 between genotypes). Data are presented as mean Ϯ S.D. Propofol at a subanesthetic dose enhanced locomotor activity per active time in WT mice (Fig. 2B) . This result implies that propofol at low doses may produce so-called disinhibition and that GABA content may play an important role for these actions of propofol. Consistent with these results, behavioral studies have shown that subanesthetic doses of diazepam also increased the distance traveled in WT mice . Although cellular mechanisms of these actions have not been fully clarified, the sensitivity to hypnotic/sedative drugs, such as propofol, may vary among GABA A receptor subtypes, regional distribution, and with developmental profile.
Reduced Sensitivity to Propofol in GAD65 Knockout
Electrophysiological Assays. How do our electrophysiological findings in vitro correlate with diminished hypnotic and immobilizing actions of propofol in vivo? It is difficult to draw any solid conclusion at this stage. It seems that effects on excitatory synapses do not contribute to diminished anesthetic actions of propofol (Fig. 3) . On the other hand, bicuculline reversed PS amplitude in the continued presence of SR95531 (Fig. 3, E and F) , suggesting that a propofol-enhanced tonic conductance is a likely candidate to contribute the genotype differences seen in our behavioral assays. It is unexpected that a phasic form of GABAergic inhibition appeared to be essentially normal in GAD65(Ϫ/Ϫ) mice. In this context, Tian et al. (1999) also reported that the frequency of sIPSCs was intact in retinal ganglion cells in GAD65(Ϫ/Ϫ) mice. We do not know the source of compensation for the synthesis of GABA being released. It is possible that GAD67 is up-regulated, although it has been reported that levels of GAD67 mRNA and protein are largely unchanged by the GAD65 mutation (Asada et al., 1996) . In any case, deleting GAD65 has little effect on the GABA content of spontaneously released synaptic vesicles in the absence of the anesthetic.
Significant genotype differences in GABA release were observed in the presence of propofol; propofol dose-dependently facilitated GABA release in WT mice but not in GAD65(Ϫ/Ϫ) mice. These presynaptic actions of propofol in WT mice are consistent with previous findings that volatile anesthetics (Banks and Pearce, 1999; MacIver, 2000, 2001) and propofol (Murugaiah and Hemmings, 1998; Bai et al., 2001 ) enhance GABA release, suggesting that, during sustained stimulation by propofol, the increase in GABA release probability is not maintained in GAD65(Ϫ/Ϫ) mice. The mobilization of vesicles and/or replenishment of vesicles at release sites that normally occur in WT mice during anesthetic application may be impaired in GAD65(Ϫ/Ϫ) mice.
Although we tried to elucidate the relative contributions of GAD65-mediated tonic inhibition to the in vivo actions of anesthetics, our electrophysiological data are still lacking any convincing in vitro evidence that tonic conductances have anything to do with the in vivo behavioral observations. We found that tonic conductance in cortical pyramidal neurons and propofol-induced enhancements of tonic conductances were significantly smaller in GAD65(Ϫ/Ϫ) mice (Fig.  4) . These genotype differences in GABAergic inhibitory tone may be, at least in part, a cellular basis underlying behavioral differences. However, taking the substantial cell-to-cell variations of tonic current into consideration, it is unlikely that small genotype difference in tonic current explain fully behavioral differences. Thus, we tentatively propose that tonic inhibition produced by GAD65-mediated GABA synthesis may contribute to, at least in part, diminished actions of propofol in GAD65(Ϫ/Ϫ) mice. Further examination will be needed to clarify the relative contributions of tonic inhibition to anesthetic-induced hypnotic actions.
Study Limitations. Although genetically modified animals offer powerful tools to investigate targeted gene function, knockout expression of GAD65 may induce changes in the composition of other proteins. Kash et al. (1999) examined whether the loss of the GAD65 gene affects postsynaptic GABA receptor density or affinity to compensate for possible defects in GABA release. Receptor-binding studies have shown that binding constants for [
3 H]-muscimol are unchanged between genotypes. Furthermore, no differences in total number of binding sites have been identified. These findings suggest that postsynaptic GABA A receptor density is unchanged in GAD65(Ϫ/Ϫ) mice. Supporting this notion, propofol similarly prolonged the decay of mIPSCs in GAD65(Ϫ/Ϫ) mice (Fig. 4) .
Determination of the appropriate concentration of propofol for use in brain slice experiments has been quite difficult because propofol concentration within the slice tissue may decline with the distance from the surface because of its high protein binding (Bieda and MacIver, 2004; Gredell et al., 2004) . A pharmacologically relevant free aqueous concentration of propofol was estimated to be 1.0 M on the basis of the blood concentration in humans (Franks, 2008) . For example, propofol concentrations, which potentiated GABA-induced chloride currents at the wild-type GABA A ␣1␤2␥2s receptor expressed in human embryonic kidney 293 cells, appeared to be 1 to 10 M (Krasowski et al., 2001) . Propofol concentrations that enhance GABA A receptors/Cl Ϫ currents in brain slice experiments were reported to be approximately 1 to 30 M (Bieda and MacIver, 2004) . This variation may be partially explained by the considerably larger concentration of propofol in the brain than in plasma or blood (Shyr et al., 1995) . Together, we think that 1 to 30 M propofol used in physiological studies might be relevant to that in propofol administration in vivo.
Several mutations in the GABA A receptor subunits have appeared to modulate in vivo propofol actions (Jurd et al., 2003) . The mutation of asparagine to methionine (N265M) in the ␤3 subunit greatly reduces the ability of propofol and etomidate to cause LORR and eliminates their ability to prevent the response to a painful stimulus, but it has little effect on the actions of volatile anesthetics. This article shows that point mutations in the GABA A receptor ␤3 subunit can greatly affect their in vivo anesthetic potencies. We have reported previously that mutations on the ␣ subunit reduce or eliminate the effects of volatile anesthetics (Nishikawa et al., 2002; Nishikawa and Harrison, 2003) , suggesting that identical sites in mediating essential components of the anesthetic state are different in propofol and volatile anesthetics. We have shown that reduced GABA content by GAD65(Ϫ/Ϫ) may explain, in part, in vivo reduced sensitivity to propofol but not ketamine. However, the degree of the effects of GAD65(Ϫ/Ϫ) is relatively small in terms of anesthetic sensitivity; for example, the shift in the dose-response curve of LORR assay (Fig. 1) is approximately 20%. Together, it is likely that GAD65-mediated GABA concentrations can modulate propofol actions on the GABA receptors, which are major target sites of the anesthetics, although our data do not directly prove this. 
Conclusions
Our data provide evidence, for the first time in vivo, that GAD65-mediated GABA synthesis plays a significant role in hypnotic and immobilizing actions of propofol.
